About US
Contact us
-
Pearl Therapeutics Reports Positive Results From PT005 TrialFor the treatment of chronic obstructive pulmonary disease Pearl Therapeutics (Pearl) has reported positive results from phase 2a dose-ranging study of PT005, a formoterol fumarate hydrofluoroalkane2010/1/6
-
Intercell Initiates Efficacy Trial For TD Vaccine System In AsiaTo evaluate efficacy and enterotoxigenic E coli incidence of vaccinated European travelers to India Intercell has started a phase II study in India as part of its clinical development program, for th2010/1/6
-
Submission of Documentation in Applications for Parametric Release of Human and Veterinary Drug Products Terminally Sterilized by Moist Heat Processes20100105(3).rar source:WEB OF FDA2010/1/5
-
Adventrx Files New Drug Application For ANX-530Includes data from one clinical bioequivalence study designed to assess the pharmacokinetic equivalence of ANX 530 and Navelbine Adventrx Pharmaceuticals (Adventrx) has submitted a new drug applicati2010/1/5
-
SFDA issues requirements for application and acceptance of administrative licensing for cosmeticsIn order to further standardize the application and acceptance of administrative licensing for cosmetics, the State Food and Drug Administration (SFDA) recently issued requirements for2010/1/5
-
Echo Therapeutics Develops Prelude SkinPrep SystemAs a platform technology for enhanced skin permeation for transdermal drug delivery Echo Therapeutics has provided updates on the development of its needle-free Prelude SkinPrep System for transderma2010/1/4
-
Special Review and Approval Procedure for Drug Registration of the State Food and Drug AdministrationSpecial Review and Approval Procedure for Drug Registration of the State Food and Drug Administration (SFDA Decree No. 21) The Special Review and Approval Procedure for Drug Re2010/1/4
-
SFDA:Provisions for Drug RegistrationSFDA:Provisions for Drug Registration (SFDA Order No. 28)Provisions for Drug Registration Chapter IGeneral Provisions Article 1 The Provisions are formulated for the purposes2010/1/4
-
SFDA:Provisions for Drug Insert Sheets and LabelsSFDA:Provisions for Drug Insert Sheets and Labels (SFDA Decree No.24) The Provisions for Drug Insert Sheets and Labels, adopted at the executive meeting of the State Food and D2009/12/31
-
SFDA:Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim)SFDA:Provisions for Import and Export of Anabolic Agents and Peptide Hormones (Interim) (SFDA Decree No. 25)The Provisions for Import and Export of Anabolic Agents and Peptide2009/12/31